Departments of Obstetrics and Gynecology, University of Utah Health Sciences Center, Salt Lake City, Utah, University of Texas Medical Branch at Galveston, Galveston, Texas, Northwestern University, Chicago, Illinois, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, Columbia University, New York, New York, University of Texas Health Science Center at Houston, Children's Memorial Hermann Hospital, Houston, Texas, University of Pennsylvania, Philadelphia, Pennsylvania, Brown University, Providence, Rhode Island, University of Alabama at Birmingham, Birmingham, Alabama, MetroHealth Medical Center, Case Western Reserve University, Cleveland, Ohio, The Ohio State University, Columbus, Ohio, University of Pittsburgh, Pittsburgh, Pennsylvania, and University of Texas at Austin, Austin, Texas; the George Washington University Biostatistics Center, Washington, DC; and the Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, Maryland.
Corresponding author: Torri D. Metz, MD, MS, Department of Obstetrics and Gynecology, University of Utah Health Sciences Center, Salt Lake City, UT; email: [email protected].
This work is funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (UG1 HD087230, UG1 HD027869, UG1 HD027915, UG1 HD034208, UG1 HD040500, UG1 HD040485, UG1 HD053097, UG1 HD040544, UG1 HD040545, UG1 HD040560, UG1 HD040512, UG1 HD087192, U10 HD036801) and the National Center for Advancing Translational Sciences (UL1TR001873). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Financial Disclosure: Torri Metz is the site Principal Investigator (PI) for a Pfizer RSV vaccination study, a Novavax RSV vaccination study, and a Gestvision study of the validity of a point-of-care preeclampsia test. She also receives royalties for two UpToDate topics on vaginal birth after cesarean. Brenna Hughes disclosed receiving funds from Merck. Cynthia Gyamfi-Bannerman disclosed that money was paid to her institution from NICHD/NHLBI and AMAG/SMFM. She has received funds from Sera Prognostics as a Medical Advisory Board Member. Alan Tita reports money was paid to his institution from Pfizer. The other authors did not report any potential conflicts of interest.
Presented at the Society for Maternal-Fetal Medicine’s 41st Annual Pregnancy Meeting, held virtually, January 25–30, 2021.
*A list of other members of the NICHD MFMU Network is available in the Appendix 1 online at https://links.lww.com/AOG/C219.
Dr. Rouse, Editor-in-Chief, and Dr. Metz, Associate Editor, Obstetrics, for Obstetrics & Gynecology, were not involved in the review or decision to publish this article.
Each author has confirmed compliance with the journal's requirements for authorship.
Published online ahead-of-print February 8, 2021.
Peer reviews and author correspondence are available at https://links.lww.com/AOG/C220.
